Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05606211 · ClinicalTrials.gov registry record

Pain in Long COVID-19: the Role of Sleep

A clinical trial of Long COVID, sponsored by Beth Israel Deaconess Medical Center.

Active
Registry status
41
Enrollment target
1
Study location

NCT05606211: Active study of Long COVID, sponsored by Beth Israel Deaconess Medical Center.

NCT05606211 is a study of Long COVID that is active but no longer recruiting, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 41 participants, below the 2,187-participant average among 50 other Long COVID trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05606211, a study of Long COVID, is active but no longer recruiting, sponsored by Beth Israel Deaconess Medical Center.

ACTIVE NOT RECRUITING
Registry status
41 participants
Enrollment target
1
Study location

Study Summary

Pain is among the most frequently reported symptoms in Long COVID, along with sleep disturbances, fatigue, and cognitive impairments. Sleep plays a critical role in maintaining a pain-free state. The goal of this study is to characterize the type and severity of pain in Long COVID, to characterize sleep and sleep disturbances in Long COVID, and to understand the role of sleep in the development and persistence of pain symptoms in Long COVID.

Primary Outcome

Daily pain severity reporting on rating scale from 0 to 10 (greater values indicate greater pain)

Conditions Studied

Long COVID

Interventions

  • OTHER No intervention

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 41 participants
Start Date 2022-10-04
Est. Completion 2025-12-30
Beth Israel Deaconess Medical Center

488 total trials

What the registry record for NCT05606211 still lists

NCT05606211 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 2,187-participant average among 50 other Long COVID trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Long COVID appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.

NCT05606211 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05606211 about?

NCT05606211 is a clinical study titled "Pain in Long COVID-19: the Role of Sleep". Pain is among the most frequently reported symptoms in Long COVID, along with sleep disturbances, fatigue, and cognitive impairments. Sleep plays a critical role in maintaining a pain-free state. The goal of this study is to characterize the type and severity of pain in Long COVID, to characterize s...

What is the current status of trial NCT05606211?

This trial is currently active not recruiting. The enrollment target is 41 participants. The study started on 2022-10-04. Estimated completion is 2025-12-30.

What conditions does trial NCT05606211 study?

This clinical trial studies the following conditions: Long COVID.

What interventions are being tested in trial NCT05606211?

The interventions under investigation include: No intervention (OTHER).

Who is sponsoring clinical trial NCT05606211?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05606211 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Long COVID

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05606211's enrollment target sits among peer trials

41 37th of 50 higher than 14 of 50 other Long COVID trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Long COVID trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03449238 · 41 participants · Phase 1

    Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients

  • NCT03900793 · 41 participants · Phase 1

    Losartan + Sunitinib in Treatment of Osteosarcoma

  • NCT04082520 · 41 participants · Phase 2

    Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

  • NCT04220190 · 41 participants · Phase 2

    RAPA-501 Therapy for ALS

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT05606211, the US trial registry maintained by the National Library of Medicine. NCT05606211 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.